CHO Pharma, Inc. (6586.TWO)
TWD 42.9
(-17.82%)
TWD 42.9
(-17.82%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -203.79 Million TWD | 58.74% |
| 2022 | -493.96 Million TWD | 34.35% |
| 2021 | -752.42 Million TWD | 20.64% |
| 2020 | -948.12 Million TWD | 23.26% |
| 2019 | -1.23 Billion TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -95.98 Million TWD | 14.77% |
| 2024 Q1 | -95.98 Million TWD | 52.9% |
| 2023 Q4 | -203.79 Million TWD | 0.0% |
| 2023 FY | -203.79 Million TWD | 58.74% |
| 2023 Q2 | -347.63 Million TWD | 1.66% |
| 2023 Q1 | -353.5 Million TWD | 28.44% |
| 2023 Q3 | -203.79 Million TWD | 41.38% |
| 2022 Q3 | -505.65 Million TWD | 0.0% |
| 2022 FY | -493.96 Million TWD | 34.35% |
| 2022 Q4 | -493.96 Million TWD | 2.31% |
| 2021 FY | -752.42 Million TWD | 20.64% |
| 2020 FY | -948.12 Million TWD | 23.26% |
| 2019 FY | - TWD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | -164.514% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 22.855% |
| Level Biotechnology Inc. | -453.9 Million TWD | 55.102% |
| Sagittarius Life Science Corp | -120.57 Million TWD | -69.024% |
| NeoCore Technology Co., Ltd. | -196.39 Million TWD | -3.765% |
| TaiMed Biologics Inc. | 499.84 Million TWD | 140.771% |
| GlycoNex Incorporation | -148.56 Million TWD | -37.172% |
| VBI | -25.31 Million TWD | -704.993% |
| GeneReach Biotechnology Corp. | 40.26 Million TWD | 606.114% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 247.681% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 22.389% |
| Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 766.466% |
| Visgeneer Inc. | 31.28 Million TWD | 751.426% |
| Mycenax Biotech Inc. | 207 Million TWD | 198.446% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 70.057% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | -51.798% |
| Neith Corporation | -150.31 Million TWD | -35.58% |
| Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 132.788% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | -253.45% |
| Enimmune corporation | -314.15 Million TWD | 35.131% |
| TaiRx, Inc. | -147.86 Million TWD | -37.819% |
| EirGenix Inc. | -4.58 Billion TWD | 95.558% |
| BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | -140.426% |
| Sunny Pharmtech Inc. | 120.87 Million TWD | 268.603% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 93.667% |
| BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 35.797% |
| Feng Chi Biotech Corp. | -19.81 Million TWD | -928.577% |
| Bio Preventive Medicine Corp. | 31.8 Million TWD | 740.674% |
| Lukas Biomedical Inc. | 50.75 Million TWD | 501.521% |
| RBC Bioscience Corporation | 422.18 Million TWD | 148.271% |
| BiOptic Inc. | 12.59 Million TWD | 1718.424% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 78.421% |
| Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | -100.808% |
| Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | -23.379% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 164.722% |
| Advagene Biopharma Co., Ltd. | -64.32 Million TWD | -216.836% |
| NaviFUS Corp. | -123.12 Million TWD | -65.511% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 375.205% |
| Sinew Pharma Inc. | -160.34 Million TWD | -27.096% |
| Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 15.751% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 39.595% |
| Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 50.612% |
| AP Biosciences Inc | -196.52 Million TWD | -3.696% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 129.589% |
| 3D Global Biotech Inc. | -11.43 Million TWD | -1681.866% |
| Pharmosa Biopharm Inc. | -829.69 Million TWD | 75.438% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 115.014% |
| Oneness Biotech Co., Ltd. | -414.87 Million TWD | 50.879% |
| Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 2.649% |
| TWi Biotechnology, Inc. | -143.86 Million TWD | -41.657% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 38.346% |
| TCI GENE Inc. | -689.25 Million TWD | 70.433% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | -71.343% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 84.434% |
| Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 1094.932% |
| NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | -100.051% |
| PharmaEngine, Inc. | -860.8 Million TWD | 76.325% |
| Savior Lifetec Corporation | -812.54 Million TWD | 74.919% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 32.062% |
| OBI Pharma, Inc. | -398.22 Million TWD | 48.825% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | 44.231% |
| Acepodia, Inc. | -6.02 Billion TWD | 96.615% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 94.009% |